Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
pfizer
8
×
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
alzheimer's disease
bristol-myers squibb
cancer
celgene
deals
eli lilly
startups
abbvie
aducanumab
astrazeneca
biogen
What
week
8
×
drug
bio
roundup
alzheimer’s
announced
biogen
biotech
chantix
companies
help
ipo
life
news
people
pfizer
popular
prescription
recall
science
smoking
stop
way
acquisitions
adu
aducanumab
amyloid
angst
annual
anti
approved
arena’s
assessed
attention
bagged
beats
bids
biggest
billions
biogen’s
Language
unset
Current search:
pfizer
×
week
×
@bgr.com
2 years ago
If you take this popular prescription medicine, stop immediately and read this
@bgr.com
2 years ago
If you take this popular prescription medication, stop right now and call your doctor
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
